Editorial. Focuses on studies made to determine the effectiveness of combining the reduced folate cofactor (6R,S) leucovorin (LV) with fluorouracil (5-FU) in the treatment of colorectal cancer. Fluoropyrimidine cytotoxicity toward murine leukemia cells; Factors affecting modulation of ternary complex formation.